We have investigated cardiac myocytes derived from human induced pluripotent stem cells 20 (iPSC-CMs) from two normal control and two family members expressing a mutant cardiac 21 troponin T (cTnT-R173W) linked to dilated cardiomyopathy (DCM). cTnT is a regulatory protein 22 of the sarcomeric thin filament. The loss of this basic charge, which is strategically located to 23 control tension, has consequences leading to progressive DCM. iPSC-CMs serve as a valuable 24 platform for understanding clinically-relevant mutations in sarcomeric proteins; however, there 25 are important questions to be addressed with regard to myocyte adaptation that we model here 26
48

Introduction 49
In experiments reported here, we have investigated cardiac myocytes derived from 50 human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from two normal and 51 two family members expressing a mutant cardiac troponin T (cTnT-R173W) linked to dilated 52 cardiomyopathy (DCM) (7, 44, 49). Family members expressing cTnT-R173W demonstrate 53 varying degrees of DCM with a most severe case occurring in a 14 year old male, who required 54 cardiac transplantation (44). cTnT is a scaffolding protein of the sarcomeric thin filament with 55 regions of interactions with cardiac troponin I (cTnI), the inhibitory unit of the troponin complex, 56
with cardiac troponin C (cTnC), the Ca 2+ -binding unit, and with tropomyosin (Tm). By positioning 57
Tm on the actin strand, cTnT has a major role in establishing the diastolic state at Ca 2+ 58 concentrations below the threshold for activation (45). cTnT is also critical for transduction of the 59
Ca
2+
-cTnC signal to cTnI and to Tm in triggering the systolic state (23). R173 of cTnT is located 60 at a hinge region between the tail of cTnT (T1), which interacts with Tm, and the head (T2), 61 which in turn interacts with cTnI-cTnT R173 (32). Thus, cTnT-R173 is strategically located to 62 participate in these control mechanisms, and it is not surprising that loss of this basic charge 63 has consequences leading to progressive DCM. 64
Despite the promise of iPSC-CMs as a valuable platform for understanding the 65 connections between mutations in sarcomeric proteins, DCM, and sudden death, there are 66 8
The perimeter of the cell was drawn by hand and ImageJ software used to determine the 165 fraction of red pixels per cell, which is a metric for the fraction of the CM volume filled by 166 phalloidin fluorescence, which is a semi-quantitative measure of F-actin content in the striated 167
cells. 168 169
Live cell video recording. 170 iPSC-CMs were examined with a Zeiss LSM Observer Z1 microscope (Zeiss, Peabody, 171 MA). Videos of 10 randomly selected fields from each dish were recorded for fifteen seconds 172 with phase microscopy (20X objective). The percent of cells beating per dish and beats per 173 minute were calculated each day for normal and mutant cells from 2-14 days after plating. 174
Detailed studies were conducted at week 1 (days 5-8) and week 2 (days 12-14). 175
176
Kymograph analysis of shortening and shortening velocity. 177
Myofibrillar contractility was measured by line scans taken along the major axis of the 178 cell as reported by our lab (5, 11). This method is analogous to echocardiography where 179 displacement of the heart wall over time is used to assess contractile function. The cells were 180 selected based on an easily defined myofibril axis for the line scan. A Zeiss 710 Confocal 181
Microscope (Zeiss, Peabody, MA) was used through a water objective on a Universal 25x/0.80 182
Imm. Corr DIC (WD=0.21mm) lens and recorded using Zen software (Zeiss, Peabody, MA). 183
Transmitted light from a differential interference contrast channel was captured from each line 184 every 7.56 ms over the course of 1000 to 5000 ms, thereby recording multiple complete and 185 regular iPSC-CM contraction cycles. Peaks of contraction are rendered and used to mark states 186 of maximum shortening and relate such distance to time, from which to calculate shortening 187 velocity. Image processing software (LSM Browser, Zeiss) was used to scale the pixel to micron9 distance as well as the time to obtain the shortening and the associated velocity in single iPSC-189 We expressed and purified recombinant cTnI employing pET3d, cTnT-Wt, cTnT-R173W 226 containing an N-terminal myc tag in pSBET, and cTnC in pET3d (24). Tn complex was 227 reconstituted and verified. Actin was isolated from rabbit fast skeletal muscle acetone powder 228 and tropomyosin was prepared from bovine cardiac ether powder. Myosin-S1 was made by 229 chymotryptic digestion of rabbit psoas muscle myosin. Myofilaments were reconstituted with 230 varying concentrations of Tn complex containing either cTnT-Wt or cTnT-R173W, 0.2 μM 231 myosin S1, 7 μM actin, and 1 μM tropomyosin. Final assay conditions were 35 mM NaCl, 5 mM 232 Representative images show myofibril formation after cryopreservation, replating and 261 one or two weeks of culture when stained for actin, α-actinin, and the nucleus (Fig 1) . Cells fixed 262 at the times stated and did not have any signs of cell death. At week 1, normal iPSC-CMs had 263 well-developed striations and the M2 mutant had striations but not as well delineated by α-264 actinin. However, the mutant M1 cells from the severely affected patient were much less 265 organized with fewer striations (Fig 1A) . At week 2, the normal cells remained striated and the 266 mutant M1 cells were improved (Fig 1B) . There was a larger range of myofibrillar architecture 267 from very low to high in the iPSC-CM population than one would find, for example, in cultured 268
NRVMs where all cells are beating and filled with striated myofibrils. 269
270
Contractility of iPSC-CMs. 271
The maximum shortening of iPSC-CMs was calculated using a kymograph (Fig 2A, B) . 272
At week 1, the average shortening and standard deviation for normal N1 was 0.89 ± 0.28 μm, 273 and N2 was 1.09 ± 0.48, which were similar to each other. In the mutant M1 cells from the 274 severely affected patient it was 0.47 ± 0.17 μm, which was significantly less than normal N1 (p< 275 0.01). However, the M2 mutant at week one was not different from the normal CMs and these 276 cells were, therefore, not subjected to analysis for longer time periods. At week 2, the average 277 shortening and standard deviation in the N1 normal cells was 0.81 ± 0.18 μm and in M1 mutant 278 cells was 0.70 ± 0.23 μm, which was significantly higher than week 1 (p<0.01) (Fig 2C) . 279
Substrate stiffness (100 kPa) and surface area adhering to the substrate can be used to 280 express shortening in terms of surface tension (5), where normal cells with greater shortening 281 generate more force than mutant cells at week 1, but have the same force by week 2. 282
Substrate stiffness is known to influence cardiomyocyte shortening (5, 11, 30) and was 283 verified with the iPSC-CMs by comparing normal iPSC-CMs plated on glass (61.9 GPa) and 284 PDMS (100 kPa) (Fig 2) . In Supplement variation from cell to cell in many parameters for all lines. Some significant differences are found 287 between N1 and M1 cells at both weeks one and two but cells from the more normal M2 patient 288 was indistinguishable from N2 in all parameters. 289
Profiles of sarcomeric proteins in iPSC-CMs. 290
In order to understand the structure/function relations in the iPSC-CMs of the DCM 291 patient more clearly, we performed gel electrophoresis to determine the protein isoform 292 populations (Fig 3) . No detectable cTnI isoform was identified by Western blot analysis of TnI 293 (Fig 3A) in iPSC-CMs, suggesting exclusive expression of the slow skeletal TnI (ssTnI) variant. 294 ssTnI is predominant in the embryonic/early neonatal stage of heart development as verified in 295 the positive controls of developing mouse heart TnI ( Fig 3A) . Substantial evidence indicates that 296 sarcomeres controlled by ssTnI rather than cTnI are resistant to deactivation by acidic pH and 297 highly sensitive to Ca 2+ (49). In contrast to the case with TnI, the TnT isoform population (Fig  298   3B ) has a relatively high cTnT3, which is the adult human isoform (1). Owing to a limited 299 number of cells to perform further analysis we have relied on relative mobility to identify TnT 300 isoforms, which we have employed extensively in past studies (20, 21). Moreover, previous 301 studies (20) from our lab investigating relative expression thin filament isoforms in the 302 developing rabbit heart indicated a lack of coordination of the developmental transition of TnI 303
and TnT isoforms, which may be influenced by adrenergic stimulation and stress. After one 304 week in culture, the normal and the cTnT-R173W iPSC-CMs both expressed a relatively high 305 percentage of β-MHC myosin heavy chain (MHC) isoform (Fig 3C) . However, by two weeks, 306 whereas the mutant percentage remained about the same as that at one week, both the normal 307 lines were mostly β-MHC, which is characteristic of the adult human heart (38) . Compared to α-308 MHC, hearts regulated by β-MHC demonstrate slower cross-bridge kinetics and increased 309 economy of contraction (unit ATPase rate/unit tension development) (39) . Taken Functional changes in the iPSC-CMs may be due in part to the altered sarcomeric 315 isoform population (Fig 3) as well as myosin ATPase activity (Fig 4) . We therefore thought it 316 important to determine more clearly how the presence of cTnT-R173W per se affects sarcomere 317 activity. It is generally found that DCM inducing mutants in thin filament protein induce a 318 depression in myofilament activity. To determine whether this is the case with cTnT-R173W, we 319 expressed wild type (wt) and mutant cTnT, and fully reconstituted a Ca 2+ -sensitive myofilament 320 preparation. Inasmuch as the other sarcomeric proteins were the same in these experiments, 321
we were able to compare the specific effects of control cTnT to mutant cTnT. We titrated the 322 thin filaments with varying concentrations of Tn complex achieving full relaxation at the 323 expected ratio of 7actins:1Tm:1Tn (Fig 4) . There was a significantly depressed ATPase rate in 324 the myofilaments reconstituted with the mutant cTnT-R173W compared to the controls. 325
326
Omecamtiv Mecarbil control studies on neonatal rat ventricular myocytes. 327
NRVMs were used as a control to study the effect of OM on shortening (Fig 5) . When 328 untreated, the average shortening was 0.95 ± 0.10 μm (Mean ± SEM), while it increased to 1.65 329 ± 0.32 μm with 200 nM, and to 2.04 ± 0.15 μm with 500 nM OM. The maximum shortening of 330 NRVM was significantly higher at the 500 nM dose compared with untreated NRVM (p<0.01), 331
but not different with the 200 nM dose. Actin FRAP dynamics in NRVM were also measured at 332 the different OM concentrations (Fig 5) . The K FRAP for the untreated group was 2.69 ± 0.02 x 10 . With the 500 nM OM treatment, the 334 actin dynamics were significantly higher (7.10 ± 1.3 x 10 -4 s -1
) than the untreated group (p<0.01). 335
Actin content in iPSC-CM with Omecamtiv Mecarbil treatment. 337
Representative images are shown for week one and week 2 (Fig 1) in normal and  338 mutant cells and when treated with 500 nM OM (Fig 6) . Given the heterogeneity of iPSC-CMs, 339
an unbiased measure of actin content was necessary. The content of assembled F-actin was 340 measured semi-quantitatively per cell by fraction the fluorescent pixels at week 1. There were 341 45% and 4% striated CMs for N1 and M1 (Fig 6B) and for 47% and 23% striated CMs for N2 342
and M2 (Fig 6C) , respectively. The fraction of striated CM volume filled by F-actin (Fig 6D) was 343 significantly higher in N1 (0.36 ± 0.14) than in M1 mutant cells (0.18 ± 0.04) Mean ± SD, p<0.01.
344
However, the F-actin fraction per cell with one week exposure to 500 nM OM the M1 mutant 345 cells increased significantly to 0.25 ± 0.04 compared to the untreated M1 0.18 ± 0.04, p<0.01. 346
The M2 mutant CMs did not change their actin content with OM treatment (Fig 6E)  347 
348
Effects of Omecamtiv Mecarbil on actin FRAP dynamics and shortening. 349
To address potential therapeutic effects of OM on actin FRAP dynamics and shortening 350 iPSC-CMs were treated with 200 nM or 500 nM OM, which had no effect on cell viability over a 351 two-week period. The dynamics of sarcomeric actin were measured at week one via FRAP from 352 cells infected with actin-GFP fusion virus to visualize the striated sarcomeres and quantify the 353 recovery profile of the fluorescence (Fig 7A) . The kinetic constant (K FRAP ) obtained from the 354 results of the curve fitting for the N1 normal cells was and for M1 mutant cells (Fig 7B) (Fig 7C) . OM did not affect the normal CMs but differences were found with a inducing thin filament mutation and altered thin filament assembly in iPSC-CMs from a severely 370 affected patient. Thus, the novel concept is presented for pathogenicity of cTnT mutations on 371 sarcomere assembly as well as contractility, rather than solely by affecting contractile 372 parameters. Electron micrographs of iPSC-CMs with the cTnT R173W mutation showed 373 myofibrillar disruption (44), but a mechanistic association with the modification in TnT remained 374 unknown. In studies reported here, the structure, actin content and function of cTnT R173W 375 mutation iPSC-CMs from the severely afflicted family member matured at a slower rate than the 376 normal iPSC-CMs, with altered actin FRAP dynamics and reduced sarcomeric assembly. These 377 findings indicate sarcomeric assembly is slower in the iPSC-CMs from a severely afflicted 378 patient and serve as evidence to support the hypothesis that the link between a TnT mutation 379 and sarcomere assembly is a maladaptive alteration in mechanical properties in the cell via 380 mechano-signal transduction pathways (40, 41). The epigenetic effects of the severity of the 381 disease in this family were noted recently (50) and were also seen here with respect to 382 contractility and actin content. 383
Previous studies (15) reported a failure in sarcomere assembly when TnT activity was 384 disrupted during zebra fish development. Those investigators concluded that TnT was important 385 for both regulation of the actin-myosin interaction and myofibrillogenesis (15) . However, to the 386 best of our knowledge, this concept has not been identified in the case of DCM in human hearts 387 or iPSC-CMs. Thus, our finding suggests a new problem that may contribute into disease 388 progression in familial DCM. The presence of both depressed sarcomeric organization and 389 muscle performance has been found in other models such as DCM induced by loss of MLP (2) 390 or by loss of nexillin (21). 391
Our data also are the first to show that a sarcomere activator, OM, acting via thick 392 filament myosin improves sarcomere shortening that had been depressed due to the cTnT-393 R173W mutation. An important aspect of our choice of this particular agent is that it has gone 394 through safety trials in humans, and has been reported to improve function in acquired heart 395 failure. In addition, there is no evidence for off target effects of OM as an inhibitor of 396 phosphodiesterase III (PDE III), or on alterations in Ca 2+ fluxes (31, 42). Recent studies from our 397 labs have reported proof of principal that OM is able to increase tension and ATPase rate of 398 sarcomeres from a DCM model with a mutation in the thin filament protein Tm (46). Indeed, with 399 one week of culture, the chronic treatment with the 500 nM dose of OM increased about 50% 400 iPSC-CM shortening with additional gains in actin accumulation over untreated mutant iPSC-401
CMs, but we found no detectable changes on actin dynamics with OM. These results suggest 402 that OM is effective in improving function by promoting the actin-myosin interaction in normal 403 cells, but not effective in overcoming the depressive affects the mutant TnT has on actin 404 dynamics. TnT can reportedly contact and generate molecular swivel for the successive 405 tropomyosin to interact equivalently with the actin filament (35). Also, tropomyosin is well-known 406 for providing stability during actin assembly (8). Thus other structural dysfunctions of TnT might 407 lead to delayed abnormal actin dynamics and assembly rate, which was also seen in this study. 408
An important novel aspect of our findings is data analyzing sarcomeric protein 409 composition in the iPSC-CMs. Comparisons of sarcomeric protein isoform composition have not 410 been generally assessed, and our studies were limited by the amount of protein available in the 411 cell preparations. Yet, an important finding is the persistence of expression of ssTnI, the 412 fetal/neonatal form of TnI. We have previously reported that variations in N-terminal TnT 413 isoforms produce different effects on sarcomere Ca-responsiveness in myofilaments controlled 414 by cTnI and ssTnI (20). It is interesting that in contrast to the case with TnI, the adult isoform 415 cTnT3 is the most abundant isoform population. Myosin isoforms also more closely resembled 416 the adult human heart (predominantly β-MHC) in normal cells and at 2 weeks were ~95% β-417
MHC, but the β-MHC isoform was about half of what was present in the normal cells at 2 weeks 418 (36, 43). Moreover, the lack of effect of OM on actin dynamics in the cells expressing the mutant 419
TnT might be partly be explained by a difference in MHC isoform population. 420
Moreover, In contrast to case with normal NRVMs, there as an intriguing lack of effect of 421 OM on IPSC shortening. This difference is not likely to be due to differences in ssTnI, which is 422 nearly identical in rat and human hearts. Figure 3 shows that there is a preponderance of the 423 adult isoform of cTnT in the IPSCs, which would not be the case in the NRVM. However, we do 424 not have a clear mechanism for why OM did not induce an increase in shortening in normal 425
IPSC. 426
The sarcomere protein composition directly corresponded with the function of human 427 iPSC-CMs, which differed after plating on physiologically soft substrates (100 kPa PDMS) 428 between normal human iPSC-CMs and those derived from a DCM patient. The freeze-thaw 429 process itself delivers a major stress to iPSC-CMs (28), but this was common to all cells. At one 430 week after plating, the M1 mutant cells had significantly less actin, poorly organized myofibrillar 431 structure and less ability to shorten than the normal cells. By two weeks after plating, the mutant 432 cells were almost indistinguishable from the normal cells. Interestingly, these findings correlate 433 with the reduction in actin assembly dynamics known to regulate myofibril growth (26, 27, 29) . . Following incubation with S1 myosin and 1 mM ATP, the rate of ATPase 680 activity was determined via malachite green assay and was found to be decreased in TnT-681 R173W mutants compared to TnT-WT at the expected stoichiometric concentration of 682 actin:tropomyosin:Tn complex (7:1:1), with similar effect at higher concentrations (7:1:2). 683 *p<0.05 compared to TnT-WT. 684 
